Pluristem Therapeutics Inc (PSTI)

[bullrider2]

PSTI had a very good Press release all the ingredients it needed for a nice run. Early heavy dumping in the beginning of a run always drive away many potential investors and buyers. Buyers is the ones who bring in lots of volume, one of the ingredients that is needed to move a stock. Pluristem has driven away its potential high volume with early heavy dumping. Maybe they can get this volume back today if they stop scaring away the heavy buyers.

The company has a very good phase study lined up. A phase III study to help save many patients from having their legs or arms amputated due to poor circulation and diseases that effect the blood flow to their legs and arms.